Sfar S - Search Results

1

An array CGH based genomic instability index (G2I) is predictive of clinical outcome in breast cancer and reveals a subset of tumors without lymph node involvement but with poor prognosis.

Bonnet F, Guedj M, Jones N, Sfar S, Brouste V, Elarouci N, Banneau G, Orsetti B, Primois C, de Lara CT, Debled M, de Mascarel I, Theillet C, Sévenet N, de Reynies A, MacGrogan G, Longy M. Bonnet F, et al. Among authors: sfar s. BMC Med Genomics. 2012 Nov 27;5:54. doi: 10.1186/1755-8794-5-54. BMC Med Genomics. 2012. PMID: 23186559 Free PMC article.

2

Comprehensive analysis of PTEN status in breast carcinomas.

Jones N, Bonnet F, Sfar S, Lafitte M, Lafon D, Sierankowski G, Brouste V, Banneau G, Tunon de Lara C, Debled M, MacGrogan G, Longy M, Sevenet N. Jones N, et al. Among authors: sfar s. Int J Cancer. 2013 Jul 15;133(2):323-34. doi: 10.1002/ijc.28021. Epub 2013 Feb 12. Int J Cancer. 2013. PMID: 23319441

3

Association of VEGF genetic polymorphisms with prostate carcinoma risk and clinical outcome.

Sfar S, Hassen E, Saad H, Mosbah F, Chouchane L. Sfar S, et al. Cytokine. 2006 Jul;35(1-2):21-8. doi: 10.1016/j.cyto.2006.07.003. Epub 2006 Sep 5. Cytokine. 2006. PMID: 16908180

4

[Human genome project: a federator program of genomic medicine].

Sfar S, Chouchane L. Sfar S, et al. Pathol Biol (Paris). 2008 May;56(3):170-5. doi: 10.1016/j.patbio.2007.12.001. Epub 2008 Mar 5. Pathol Biol (Paris). 2008. PMID: 18325690 French.

5

Genetic analysis of hereditary multiple exostoses in Tunisian families: a novel frame-shift mutation in the EXT1 gene.

Sfar S, Abid A, Mahfoudh W, Ouragini H, Ouechtati F, Abdelhak S, Chouchane L. Sfar S, et al. Mol Biol Rep. 2009 Apr;36(4):661-7. doi: 10.1007/s11033-008-9226-3. Epub 2008 Mar 11. Mol Biol Rep. 2009. PMID: 18330718

6

TSP1 and MMP9 genetic variants in sporadic prostate cancer.

Sfar S, Saad H, Mosbah F, Gabbouj S, Chouchane L. Sfar S, et al. Cancer Genet Cytogenet. 2007 Jan 1;172(1):38-44. doi: 10.1016/j.cancergencyto.2006.07.014. Cancer Genet Cytogenet. 2007. PMID: 17175378

7

Association of HSP70-hom genetic variant with prostate cancer risk.

Sfar S, Saad H, Mosbah F, Chouchane L. Sfar S, et al. Mol Biol Rep. 2008 Sep;35(3):459-64. doi: 10.1007/s11033-007-9107-1. Epub 2007 Jun 20. Mol Biol Rep. 2008. PMID: 17578680

8

Combined effects of the angiogenic genes polymorphisms on prostate cancer susceptibility and aggressiveness.

Sfar S, Saad H, Mosbah F, Chouchane L. Sfar S, et al. Mol Biol Rep. 2009 Jan;36(1):37-45. doi: 10.1007/s11033-007-9149-4. Epub 2007 Oct 5. Mol Biol Rep. 2009. PMID: 17917789

9

Synergistic effect and VEGF/HSP70-hom haplotype analysis: relationship to prostate cancer risk and clinical outcome.

Sfar S, Saad H, Mosbah F, Chouchane L. Sfar S, et al. Hum Immunol. 2010 Apr;71(4):377-82. doi: 10.1016/j.humimm.2010.01.017. Epub 2010 Feb 4. Hum Immunol. 2010. PMID: 20096741

10

A novel CASR mutation in a Tunisian FHH/NSHPT family associated with a mental retardation.

Sfar S, Bzéouich AA, Kerkeni E, Bouaziz S, Najjar MF, Chouchane L, Monastiri K. Sfar S, et al. Mol Biol Rep. 2012 Mar;39(3):2395-400. doi: 10.1007/s11033-011-0990-0. Epub 2011 Jun 12. Mol Biol Rep. 2012. PMID: 21667241

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

64 results

Search Page

Filters